 JanOne Inc NASDAQ: JAN shares are trading higher by 42.40 at 3.56 after the company announced that a patent was issued that covers a method of improving nerve function using JAN101. JAN101 formerly known as TV1001SR, is a potential treatment for peripheral artery disease PAD, a. 